MARKETS
Analyst Actions

B of A Securities Initiates Coverage On Axogen with Buy Rating, Announces Price Target of $52

Oct 12, 2026 · 06:37 AM ET· updated 11h ago

B of A Securities analyst Travis Steed initiates coverage on Axogen (NASDAQ:AXGN) with a Buy rating and announces Price Target of $52.

Share
Why It Matters

A big investment bank started following Axogen and said it looks good. They think the stock could be worth $52 per share eventually.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.